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Abstract: Mean platelet volume (MPV) as an indicator of platelet activation is a subject of many studies. Since the 
introduction of automated hematology analyzers, many authors described mean platelet volume as a marker for different 
pathologic conditions. It is also known that numerous preanalytical conditions could affect MPV results. Specimens are 
usually tested several hours after blood collection. There are some specific hematology analyzers which are in use by 
the majority of hematology laboratories. This review demonstrates some important aspects related to MPV measurement 
in routine laboratory. 
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INTRODUCTION 
Mean platelet volume (MPV) has been discussed as 
an indicator of platelet function: larger platelets are 
more reactive and related to a shortened bleeding time. 
It is established that the platelet volume is correlated 
with platelet activation and function [1]. Small platelets 
have lower functional abilities than larger ones [2]. 
Changes of MPV values have been shown in different 
patient groups [3-5]. MPV is universally available, an 
easy test to perform and economic in routine 
laboratories. Besides these attractive properties, there 
are some drawbacks concerning MPV measurements. 
We try to review some of the preanalyticalvariabilities 
related to platelet volume enumeration. 
METHODS FOR MPV MEASUREMENT 
Different analyzers have been used for MPV 
measurement and every finding specifically deserves 
mention, because the method and type of 
instrumentation is one of the co-variables to influence 
the results. Platelet volume has been measured by 
three different techniques in routine laboratories [6]. 
The electrical impedance method is based on the 
Coulter principle. When a dilute suspension of cells 
pass through a small aperture, each cell briefly 
changes the resistance of the electrical current 
between two electrodes on both sides of the aperture. 
Electrical impedance is proportional to the volume of 
the particle traversing the aperture, and so this method  
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can estimate cell sizing and counting. A major 
disadvantage of the impedance method is that cell size 
analysis cannot discriminate large platelets from other 
similarly sized particles, such as small or fragmented 
red cells [7]. 
In optical method, a diluted blood specimen passes 
through the sensing zone, which a beam of laser light 
is focused. Scattered light is detected at a specific 
angle (one-dimensional) or two specific angles (two-
dimensional), and converted to an electric impulse. The 
number of impulses generated is proportional to the 
number and volume of cells [8].  
The third and new possibility to measure platelet 
count and platelet volume is optical fluorescence, 
which has been introduced recently on the 
Sysmexanalyzers. A polymethine dye is used in this 
technology to stain platelets and simultaneous counting 
of fluorescent platelets. The optical fluorescence count 
is more reliable at low platelet count and more 
appropriate for making clinical decisions, even for 
platelet transfusion [9].  
It has been shown that for values in the normal 
range, three different methods demonstrated 20-25% 
variation in the measurement [6]. Another study 
calculated up to 40% difference between MPV 
measurements by impedance and optical methods [10]. 
ANTICOAGULANTS 
Different anticoagulants and reagents is in use to 
minimize preanalytical activation in vitro, but most of 
them are hard to apply for routine laboratory because 
of impracticality [11]. It has been shown that standard 
20    Global Journal of Hematology and Blood Transfusion, 2016, Vol. 3, No. 1 Zsóri et al. 
phlebotomy does not activate platelets significantly with 
different anticoagulants [12]. Salts of EDTA 
(dipotassium or tripotassium EDTA, disodium EDTA) 
with around 1.5 mg/ml of blood generally used for 
routine hematology testing and Na3-citrate (0.109 mol/l 
or 0.129 mol/l) generally used for routine coagulation 
testing [13]. These anticoagulants have been used and 
studied for their roles in stabilization of platelet 
parameters [11, 14-24]. Thompson et al found K3EDTA 
reliable anticoagulant for MPV evaluation after two 
hours of blood drowning, and Na-citrate proved as 
unreliable [14]. A different research group by using 
blood samples containing K3EDTA or Na2EDTA and 
impedance method demonstrated significant continuing 
to increase MPV over seven hours after phlebotomy 
[15]. Blood samples anticoagulated with citrate 
revealed the same trend. Macey et al showed platelet 
volume measured by K3EDTA anticoagulated blood 
and optical method was reliable two hours 
postvenesection [11]. Another study by the impedance 
method revealed that both EDTA and citrate are 
reliable anticoagulants after one hour of sampling [16]. 
On the contrary, McShine et al observed a significant 
increase of MPV in K3EDTA samples and decreased in 
Na3citrated samples by impedance method after one 
hour of blood incubation at ambient temperature, which 
became stable after approximately four hours [20]. The 
same pattern of results was also obtained using optical 
methods, however, higher MPV results were observed 
for EDTA samples.  
Cord blood has been stored in EDTA at ambient 
temperature for four hours, and measured by 
impedance method presented no significant change of 
MPV results compare to time zero [17]. They 
demonstrated that MPV was significantly increased 
after 6 hours of venesection at room temperature and it 
was in accordance with markedly elevated CD62P as a 
marker of platelet activation. Lancé and co-workers 
concluded that best time to measure MPV from EDTA 
and sodium-citrate anticoagulated samples is 120 and 
60 minutes after venipuncture, respectively [18]. Diaz-
Ricard et al. demonstrated that MPV in EDTA 
anticoagulated blood did not significantly increased 
compared to baseline during the first three hours of 
blood drawing by optical method [19]. They measured 
samples by impedance method and depicted a 
reference range for each anticoagulant. 
K3EDTA is recommended by the International 
Council for Standardization in Hematology as the 
anticoagulant of choice for complete blood count [25]. 
Several studies have been published on the stability of 
MPV results against various conditions. Lance et al. 
demonstrated that platelets swell in the first two hours 
of phlebotomy in EDTA and in the first hour in citrate by 
impedance method [18]. They also concluded that 
platelet size stored in citrate is significantly smaller 
compared to those stored in EDTA. But some 
researches show MPV may be measured in sodium 
citrate with a better accuracy and reproducibility than in 
EDTA. Furthermore, such measurements are not 
influenced by incubation time, unlike for EDTA [22]. In 
blood collected in K3EDTA, there was an increase in 
MPV in the first two hours, but sodium citrate proved 
unreliable for the measurement of MPV [14]. 
Trowbridge et al. found EDTA an unreliable 
anticoagulant to measure platelet volume [10]. On the 
contrary, Reardon et al showed MPV to be stabilized 
by sodium citrate and prostaglandin E1 together by the 
impedance method but not optical method [24]. In 
another study, MPV measured by fluorescent flow 
cytometry method and significantly increased in EDTA 
after three hours incubation at room temperature [26]. 
According to their results, false higher MPV can be 
overcome by sample storage at 4°C. 
DISCUSSION AND CONCLUSION 
Pre-analytical variables, such as storage time and 
temperature, type of anticoagulant and methodology of 
measurement, affect the evaluation of MPV. Even 
different concentrations of a specific anticoagulant 
result in various platelet swelling [22]. Artificial platelet 
swelling and shape change after addition of 
anticoagulant to the sample is known for a while [27]. 
The effect of EDTA on platelet structure is not 
completely understood. However, it is partly explained 
by modifications of both the membranes lining the 
canalicular system and those forming the platelet cell 
wall by exposure of platelets to EDTA [28]. Besides, 
phosphorylation patterns of platelet proteins change by 
exposure to EDTA [19].  
As an MPV increases over time by exposure to 
some anticoagulants, this elevation was shown to be 
proportional to the delay in time between blood 
sampling and laboratory analysis. For reliable MPV 
measurement, researchers must carefully control the 
possible influence of anticoagulant on the MPV, either 
standardizing the incubation time between phlebotomy 
and analysis or using an alternative anticoagulant or 
additive. 
Platelet aggregation by any means causes incorrect 
MPV measurement. Although EDTA is used in the 
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everyday hematological laboratory, it induces 
pseudothrombocytopenia [29], and heparin or citrate 
usage instead of EDTA did not overcome in vitro 
platelet aggregation [30]. Alternative anticoagulant has 
been suggested to inhibit pseudothrombocytopenia [20, 
31-33]. 
Difference between results from different authors 
may come from a number of individuals included in the 
study, different method of comparison, or use of 
different physical principles to measure MPV. Neither 
impedance method, nor optical method takes into 
account the shape change of platelets [34]. As a result, 
these methods do not agree with each other. 
In conclusion, until the standardization of MPV 
measurements for routine practical use, thorough 
description of MPV assessment is necessary i.e., 
technique, type and concentration of anticoagulant, 
storage time and temperature [35]. In this way, we may 
increase use of MPV as an effective diagnostic and 
prognostic factor in different pathologic disorders. 
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